This narrative review outlines the pathophysiology, risk factors, clinical presentation, and management of radiotherapy-induced cardiotoxicity in cancer survivors.
Radiotherapy cardiotoxicity warrants long-term surveillance in survivors; leaves open optimal prevention strategies pending prospective trials.
Contemporary treatment modalities for malignancy including radiation therapy have led to improved survival. However treatment related complications manifesting later in life including cardiovascular disease has led to survivors exhibiting a lower long term survival rate, when compared to age matched controls. This narrative review will discuss the pathophysiology, risk factors, clinical presentation, management and preventative techniques related to radiotherapy-induced cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Adams et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: